O, F., E, A., PS, H., GL, F., K, T., E, H. H., . . . K, S. C. (2026). A conceptual health economic modelling framework to assess the cost-effectiveness of molecular target-driven treatment regimens in oncology. Acta oncologica (Stockholm, Sweden), 65, 141. https://doi.org/10.2340/1651-226X.2026.45088
Chicago Style (17th ed.) CitationO, Frisell, Aas E, Henkel PS, Fagereng GL, Taskén K, Hallersjö Hult E, Lindgren P, and Steen Carlsson K. "A Conceptual Health Economic Modelling Framework to Assess the Cost-effectiveness of Molecular Target-driven Treatment Regimens in Oncology." Acta Oncologica (Stockholm, Sweden) 65 (2026): 141. https://doi.org/10.2340/1651-226X.2026.45088.
MLA (9th ed.) CitationO, Frisell, et al. "A Conceptual Health Economic Modelling Framework to Assess the Cost-effectiveness of Molecular Target-driven Treatment Regimens in Oncology." Acta Oncologica (Stockholm, Sweden), vol. 65, 2026, p. 141, https://doi.org/10.2340/1651-226X.2026.45088.